Literature DB >> 9043115

The topoisomerase I gene from Candida albicans.

Weidong Jiang1, David Gerhold2, Eric B Kmiec2, Melinda Hauser3, Jeffrey M Becker3, Yigal Koltin1.   

Abstract

We report here the cloning of the Candida albicans genomic topoisomerase I gene (TOP1) by use of PCR and subsequent hybridization. The predicted protein sequence shared 58.8% identity with the Saccharomyces cerevisiae topoisomerase I and 30-50% identity with other eukaryotic topoisomerase I proteins. A conditional gene disruption strain (CWJ477) was constructed so that one copy of TOP1 was deleted and the other copy of TOP1 was placed under a regulatable promoter. Under repressed conditions, cells grew slowly and cell morphology was abnormal. The virulence of CWJ477 was markedly reduced in a mouse model system, and that of the single gene knockout-strain was slightly attenuated, indicating that TOP1 might play a role in the infection of C. albicans in mice in a dose-dependent manner. Despite the reduced virulence of both the single and double knockout strains, viable cells of the pathogen were recovered from the kidneys as late as 22 d post-infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9043115     DOI: 10.1099/00221287-143-2-377

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  10 in total

1.  Topoisomerase I is essential in Cryptococcus neoformans: role In pathobiology and as an antifungal target.

Authors:  M Del Poeta; D L Toffaletti; T H Rude; C C Dykstra; J Heitman; J R Perfect
Journal:  Genetics       Date:  1999-05       Impact factor: 4.562

2.  Cloning and sequencing of a Candida albicans catalase gene and effects of disruption of this gene.

Authors:  D R Wysong; L Christin; A M Sugar; P W Robbins; R D Diamond
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Antifungal activity of eupolauridine and its action on DNA topoisomerases.

Authors:  Shabana I Khan; Alison C Nimrod; Mohammed Mehrpooya; John L Nitiss; Larry A Walker; Alice M Clark
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 4.  Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action.

Authors:  M E Cardenas; M C Cruz; M Del Poeta; N Chung; J R Perfect; J Heitman
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

5.  Altered expression of selectable marker URA3 in gene-disrupted Candida albicans strains complicates interpretation of virulence studies.

Authors:  J Lay; L K Henry; J Clifford; Y Koltin; C E Bulawa; J M Becker
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

6.  Candida albicans septin mutants are defective for invasive growth and virulence.

Authors:  Amy J Warenda; Sarah Kauffman; Taylor P Sherrill; Jeffrey M Becker; James B Konopka
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

7.  Antifungal Activity of Capridine β as a Consequence of Its Biotransformation into Metabolite Affecting Yeast Topoisomerase II Activity.

Authors:  Iwona Gabriel; Kamila Rząd; Ewa Paluszkiewicz; Katarzyna Kozłowska-Tylingo
Journal:  Pathogens       Date:  2021-02-09

Review 8.  DNA damage checkpoint and repair: From the budding yeast Saccharomyces cerevisiae to the pathogenic fungus Candida albicans.

Authors:  Shuangyan Yao; Yuting Feng; Yan Zhang; Jinrong Feng
Journal:  Comput Struct Biotechnol J       Date:  2021-11-25       Impact factor: 7.271

Review 9.  'Acridines' as New Horizons in Antifungal Treatment.

Authors:  Iwona Gabriel
Journal:  Molecules       Date:  2020-03-25       Impact factor: 4.411

10.  Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus.

Authors:  Alexandra Brand; Donna M MacCallum; Alistair J P Brown; Neil A R Gow; Frank C Odds
Journal:  Eukaryot Cell       Date:  2004-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.